On Tuesday, Tango Therapeutics Inc (NASDAQ: TNGX) was 8.07% up from the session before settling in for the closing price of $2.85. A 52-week range for TNGX has been $2.59 – $13.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 132.62% over the last five years. When this article was written, the company’s average yearly earnings per share was at -11.20%. With a float of $49.85 million, this company’s outstanding shares have now reached $107.41 million.
The firm has a total of 140 workers. Let’s measure their productivity. In terms of profitability, gross margin is 95.68%, operating margin of -322.0%, and the pretax margin is -283.95%.
Tango Therapeutics Inc (TNGX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tango Therapeutics Inc stocks. The insider ownership of Tango Therapeutics Inc is 53.59%, while institutional ownership is 48.09%. The most recent insider transaction that took place on Nov 18 ’24, was worth 37,800. In this transaction Director of this company bought 10,000 shares at a rate of $3.78, taking the stock ownership to the 31,250 shares. Before that another transaction happened on Nov 14 ’24, when Company’s Director bought 10,000 for $3.62, making the entire transaction worth $36,200. This insider now owns 21,250 shares in total.
Tango Therapeutics Inc (TNGX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -11.20% per share during the next fiscal year.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
You can see what Tango Therapeutics Inc (TNGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.17, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.43 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Analysing the last 5-days average volume posted by the [Tango Therapeutics Inc, TNGX], we can find that recorded value of 0.85 million was lower than the volume posted last year of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 32.08%. Additionally, its Average True Range was 0.28.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 5.27%, which indicates a significant decrease from 46.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 95.05% in the past 14 days, which was lower than the 113.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.29, while its 200-day Moving Average is $7.04. Now, the first resistance to watch is $3.17. This is followed by the second major resistance level at $3.25. The third major resistance level sits at $3.41. If the price goes on to break the first support level at $2.93, it is likely to go to the next support level at $2.77. Should the price break the second support level, the third support level stands at $2.69.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
There are 107,418K outstanding shares of the company, which has a market capitalization of 330.85 million. As of now, sales total 36,530 K while income totals -101,740 K. Its latest quarter income was 11,610 K while its last quarter net income were -29,170 K.
